With the public availability of ChatGPT 3.5 in fall 2022 at the latest, artificial intelligence in the sense of large language models (L LMs) is on everyone’s lips. However, it is often forgotten that this is only the provisional end point of decades of development of artificial intelligence, which, despite its great potential, still has many limitations. The question for practising doctors is how this technology can be used sensibly in everyday clinical practice – and how it should not be used.
Autoren
- Dr. med. Lukas Dürst
- Dr. med. Marc Oertle
Publikation
- CARDIOVASC
Related Topics
You May Also Like
- Case Report
6-year-old child with central retinal artery occlusion
- Low grade serous ovarian carcinoma (LGSOC)
Opening up new horizons through combination therapies
- Rare diseases
Yellow nail and Swyer-James syndrome
- Results of a systematic review and meta-analysis
Physical activity as a therapeutic approach for depression and anxiety disorders
- Underestimated risk - findings from a US cohort
Heart failure after myocardial infarction
- AI in neurology
Control instead of a flood of data: AI makes big data and wearables usable
- From symptom to diagnosis
Abdominal pain – Sprue
- Case Report